Paper

Ciliogenic pancreatopathy reveals a link between ciliopathies and exocrine pancreatic disease

Flasse, Lydie, Achouri, Younes, Saunier, Sophie, Valentine Gillion, Jacquemin, Patrick, Haumaitre, Cecile, Serafin, Alice, Garcia De Herreros, Antonio, Moro, Joel, Viau, Amandine, Scheers, Isabelle, Bodson, Charlotte, Lemaigre, Frederic, Rajput, Memoona, Godefroid, Nathalie, Loriot, Axelle, Lopez-Muneta, Leyre, Grapin-Botton, Anne, Wilsch-Brauninger, Michaela, Poree, Esther, Rovira, Meritxell

2026

Overview

Background: While pancreatic cysts have been described in syndromic ciliopathies, the pancreas is not commonly recognized as a target organ. However, several ciliary gene knockout mouse models develop a pancreatic phenotype combining acinar atrophy and adipocyte accumulation, hereby called adipopancreatosis, suggesting a link between ciliary dysfunction and pancreatic disease. Objective: We investigated whether mutations in ciliopathy-associated genes are linked to pancreatic dysfunction in humans. Design: We analyzed a cohort of 341 patients with pediatric-onset pancreatic anomalies and characterized the pancreatic phenotype of new mouse models with conditional Nphp3 inactivation or bearing Nphp3 mutations recapitulating human mutations. In patients, pancreatic fat content was quantified using Dixon-MRI. Results: Mutations in the cilium-related HNF1B and NPHP3 were identified in patients presenting with both renal and pancreatic dysfunction. Nphp3 mutant mice developed acinar atrophy, adipopancreatosis, and moderate inflammation. Adipocytes in the pancreas exhibited a white adipocyte-like profile and likely originated from mesothelial-derived fibroblasts. Reduced numbers and altered length of ductal cilia were monitored. Interestingly, secretory canaliculi, typically unnoticed structures found within and between acinar cells and connected to the acinar lumen, exhibited a microcystic morphology. Consistent with the mouse phenotype, Dixon-MRI revealed significantly increased pancreatic fat content in patients with HNF1B and NPHP3 mutations. Conclusion: We describe a previously unrecognized pancreatic manifestation of ciliopathies, which we name ciliogenic pancreatopathy. Patients with known ciliopathy-causing mutations should be evaluated for this pancreatic condition, particularly those with kidney disease, as concomitant exocrine pancreatic insufficiency may further compromise renal function or the outcome of kidney graft.Competing Interest StatementThe authors have declared no competing interest.

• Publisher: Cold Spring Harbor Laboratory Press
• Subject: Acinar cells / Adipocytes / Animal models / Atrophy / Cilia / Genotype & phenotype / Kidney diseases / Kidney transplantation / Magnetic resonance imaging / Mutation / Pancreas / Pancreatic diseases / Pediatrics / Phenotypes / Renal function